The digital oncology market is revolutionizing cancer care by integrating AI and data analytics into treatment and management, enabling personalized therapies, early detection, and enhanced patient monitoring. This innovation is attracting significant investment and partnerships to improve cancer care. Some of the recent news about digital oncology frontrunner indicate the large interest in leading and well know digital solution providers.
- Thyme Care raised $95 million in June 2024, following a $60 million Series B round less than a year earlier.
- Osara Health partnered with Guardian Life Insurance to deliver its 12-week Cancer Coach program, focusing on mental health and wellness for cancer patients.
- Elekta and Merck & Co. (MSD) joined forces to develop digital monitoring for renal cell carcinoma via the Kaiku Health platform.
- Mika Health collaborated with AstraZeneca and Daiichi Sankyo through the UNITE program to support breast cancer patients in Switzerland with mental health coaching, AI recommendations, and symptom monitoring.
- Sidekick Health acquired PINK!, creator of the DiGA-listed breast cancer support app, PINK Coach.
While the front-runners of the digital oncology market have long been under the radar of partners and investors, the "hidden champions" are as well making significant strides and contributing to the further growth of this market segment. Hidden champions show dynamic growth, are ability to execute and target a large addressable market.
Healthcare companies that wants to partner with a digital oncology solution provider should look at hidden champions for lower partnership costs, often more flexibility and less risks.
Top 10 hidden champions are shown in the chart.
The Top10 hidden champions are selected based on their services and performance across key metrics including Dynamism, Readiness to Execute, and Aspiration (source: R2GConnect)
Dynamism assesses ongoing growth of the companies since their inception, by taking the financial sturdiness of their business into account, highlighting their sustainability as a stand-alone business. Companies like Quibim, Huna, Genomate Health and Turbine stand out with their robustness and continuous growth.
Readiness to Execute evaluates a company’s readiness in scaling-up, with comprehensive business and distribution models, experience and size of its team, and its awareness of the competitive market landscape. Fimo Health, Saventic Health and SymBioSys are some of the companies having strong competence in planning and executing business strategies to stand out in the competitive digital oncology segment.
Aspiration takes a look at the value proposition and implementation of emerging technologies and AI, available patents, pilot and clinical studies, and the addressable market sizes. Mobio Interactive and SymBioSys show higher aspiration results, while others have a room for improvement in clinical studies and patents.
To find out which company best suits your requirements, summarize what you are looking for in a briefing (open call) on R2Gconnect, and tap into the digital oncology solution providers that best fit to your request. Search for the best partners in our growing startup Radar database (8,200+ startups). Find your hidden champion. Get started and create your first briefing at www.R2GConnect.com or book a demo session at https://www.r2gconnect.com/r2g-demo-booking